Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
596 hedge funds and large institutions have $12.5B invested in Exact Sciences in 2021 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 202 increasing their positions, 185 reducing their positions, and 96 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
1.29% more ownership
Funds ownership: 92% → 93.29% (+1.3%)
9% more repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 185
3% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 96
1% less funds holding
Funds holding: 602 → 596 (-6)
17% less capital invested
Capital invested by funds: $15.1B → $12.5B (-$2.59B)
18% less call options, than puts
Call options by funds: $164M | Put options by funds: $201M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$370M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$156M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$108M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$106M |
| 5 |
EC
Eminence Capital
New York
|
+$73.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$416M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$114M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$53.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$51M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$46.6M |
EXAS Hedge Fund Activity: Q4 2021 in Review
596 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2021, worth a combined $12.5B — down 17% from $15.1B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new EXAS positions and 96 closed out — a net gain of 3 holders — while 202 added to existing stakes and 185 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $370M. The largest seller was T. Rowe Price Associates, cutting an estimated $416M.
- 596 institutional investors held Exact Sciences (EXAS) as of Q4 2021, down from 602 in Q3 2021.
- Funds reported $12.5B of Exact Sciences stock for Q4 2021, down 17% quarter-over-quarter.
- 99 funds opened new Exact Sciences positions in Q4 2021 and 96 closed out, a net change of +3 holders.
- The largest Exact Sciences buyer in Q4 2021 was Wellington Management Group, an estimated $370M added.
- The largest Exact Sciences seller in Q4 2021 was T. Rowe Price Associates, an estimated $416M sold.
Based on aggregated 13F filings for Q4 2021.